Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients
Conditions: Salivary Gland Cancer; Salivary Duct Carcinoma; Adenoid Cystic Carcinoma Intervention: Drug: Lutetium-177-PSMA-I&T Sponsors: Radboud University; Dutch Cancer Society Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials